Octreotide treatment for sulfonylurea-induced hypoglycaemia

Med J Aust. 2004 May 17;180(10):540-1; author reply 541. doi: 10.5694/j.1326-5377.2004.tb06064.x.
No abstract available

Publication types

  • Case Reports
  • Comment
  • Letter

MeSH terms

  • Aged
  • Blood Glucose / analysis
  • Diabetes Mellitus, Type 2 / blood
  • Diabetes Mellitus, Type 2 / drug therapy*
  • Gliclazide / therapeutic use
  • Glyburide / therapeutic use
  • Humans
  • Hypoglycemia / chemically induced*
  • Hypoglycemia / drug therapy
  • Hypoglycemic Agents / adverse effects*
  • Male
  • Octreotide / therapeutic use*
  • Sulfonylurea Compounds / adverse effects*
  • Treatment Outcome

Substances

  • Blood Glucose
  • Hypoglycemic Agents
  • Sulfonylurea Compounds
  • Gliclazide
  • Octreotide
  • Glyburide